RPS3AP50

Across TCGA pan-cancer cohorts, RPS3AP50 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of RPS3AP50’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where RPS3AP50 RNA is repressed in tumor relative to normal tissue. In most cancer types RPS3AP50 is over-expressed in tumor, although a few such as UCEC show the opposite, repressed pattern.

UCEC are the cancer types where RPS3AP50 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS3AP50 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	II,III,IV	−0.133	.021	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

RPS3AP50–UCEC

Open the UCEC breakdown →